These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19671770)

  • 1. Public knowledge of benefits of breast and prostate cancer screening in Europe.
    Gigerenzer G; Mata J; Frank R
    J Natl Cancer Inst; 2009 Sep; 101(17):1216-20. PubMed ID: 19671770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Public knowledge of benefits of breast and prostate cancer screening in Europe.
    Brenner H; Heywang-Köbrunner S; Becker N
    J Natl Cancer Inst; 2010 Mar; 102(5):356; author reply 356-7. PubMed ID: 20075365
    [No Abstract]   [Full Text] [Related]  

  • 3. Numbers needed to decide.
    Woloshin S; Schwartz LM
    J Natl Cancer Inst; 2009 Sep; 101(17):1163-5. PubMed ID: 19671771
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.
    Wever EM; Draisma G; Heijnsdijk EA; Roobol MJ; Boer R; Otto SJ; de Koning HJ
    J Natl Cancer Inst; 2010 Mar; 102(5):352-5. PubMed ID: 20142584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What should men know about prostate-specific antigen screening before giving informed consent?
    Chan EC; Sulmasy DP
    Am J Med; 1998 Oct; 105(4):266-74. PubMed ID: 9809686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countries.
    Wegwarth O; Widschwendter M; Cibula D; Sundström K; Portuesi R; Lein I; Rebitschek FG;
    BMJ Open; 2018 Dec; 8(12):e023789. PubMed ID: 30593552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for breast and prostate cancers: moving toward transparency.
    Newman DH
    J Natl Cancer Inst; 2010 Jul; 102(14):1008-11. PubMed ID: 20498425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Online Information-Seeking and Adherence to Guidelines for Breast and Prostate Cancer Screening.
    Kim H; Filson C; Joski P; von Esenwein S; Lipscomb J
    Prev Chronic Dis; 2018 Apr; 15():E45. PubMed ID: 29679480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The accuracy and effectiveness of routine population screening with mammography, prostate-specific antigen, and prenatal ultrasound: a review of published scientific evidence.
    Woolf SH
    Int J Technol Assess Health Care; 2001; 17(3):275-304. PubMed ID: 11495374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
    Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
    J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
    Pron G
    Ont Health Technol Assess Ser; 2015; 15(10):1-64. PubMed ID: 26366236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.
    Draisma G; Etzioni R; Tsodikov A; Mariotto A; Wever E; Gulati R; Feuer E; de Koning H
    J Natl Cancer Inst; 2009 Mar; 101(6):374-83. PubMed ID: 19276453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of information about the benefits and harms of mammography on women's decision-making: study protocol for a randomized controlled trial.
    Carles M; Martínez-Alonso M; Pons A; Pérez-Lacasta MJ; Perestelo-Pérez L; Sala M; Vidal C; Garcia M; Toledo-Chávarri A; Codern N; Feijoo-Cid M; Romero A; Pla R; Soler-González J; Castells X; Rué M;
    Trials; 2017 Sep; 18(1):426. PubMed ID: 28899412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammography, routine ultrasonography in pregnancy, and PSA screenings in Italy.
    Favaretti C; De Pieri P
    Int J Technol Assess Health Care; 2001; 17(3):358-68. PubMed ID: 11495379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National evidence on the use of shared decision making in prostate-specific antigen screening.
    Han PK; Kobrin S; Breen N; Joseph DA; Li J; Frosch DL; Klabunde CN
    Ann Fam Med; 2013; 11(4):306-14. PubMed ID: 23835816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How a deliberative approach includes women in the decisions of screening mammography: a citizens' jury feasibility study in Andalusia, Spain.
    Baena-Cañada JM; Luque-Ribelles V; Quílez-Cutillas A; Rosado-Varela P; Benítez-Rodríguez E; Márquez-Calderón S; Rivera-Bautista JM
    BMJ Open; 2018 May; 8(5):e019852. PubMed ID: 29730621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].
    Giménez N; Filella X; Gavagnach M; Allué JA; Pedrazas D; Ferrer F;
    Semergen; 2018 Sep; 44(6):409-419. PubMed ID: 29574008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involving a Citizens' Jury in Decisions on Individual Screening for Prostate Cancer.
    Mosconi P; Colombo C; Satolli R; Carzaniga S; ;
    PLoS One; 2016; 11(1):e0143176. PubMed ID: 26751212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prostate cancer pseudo-epidemic.
    Adami HO
    Acta Oncol; 2010 Apr; 49(3):298-304. PubMed ID: 20397765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends in prostate cancer mortality show a continuous decrease in several countries.
    Bouchardy C; Fioretta G; Rapiti E; Verkooijen HM; Rapin CH; Schmidlin F; Miralbell R; Zanetti R
    Int J Cancer; 2008 Jul; 123(2):421-429. PubMed ID: 18452171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.